CPRX Carmen Jeffrey Del sells $256K worth of shares
Nov 29, 2025, 5:35 AM
0.00%
What does CPRX do
Catalyst Pharmaceuticals, based in Coral Gables, Florida, develops and commercializes novel medicines for rare diseases, including FIRDAPSE for Lambert-Eaton Myasthenic Syndrome and AGAMREE for Duchenne Muscular Dystrophy. The company, which went public in 2006, employs 167 people.
Carmen Jeffrey Del sold 10,983 shares of CPRX on 26 November at $23.33 per share, worth a total of $256K. They now own 3,962 CPRX shares, or a 73% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.